Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment. (June 2022)
- Record Type:
- Journal Article
- Title:
- Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment. (June 2022)
- Main Title:
- Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment
- Authors:
- Turhan, Gülce
Küçük, Haluk
Isik, Esin Ozturk - Abstract:
- Highlights: (2+1)D Convolutional Neural Network method was proposed to distinguish Mild Cognitive Impairment from Alzheimer Disease. Compared to 3D CNN methods (2+1)D provided better accuracy with an almost two times faster performance. Abstract: Background and objective: Dementia refers to the loss of memory and other cognitive abilities. Alzheimer's disease (AD), which patients eventually die from, is the most common cause of dementia. In USA, %60 to %80 of dementia cases, are caused by AD. An estimate of 5.2 million people from all age groups have been diagnosed with AD in 2014. Mild cognitive impairment (MCI) is a preliminary stage of dementia with noticeable changes in patient's cognitive abilities. Individuals, who bear MCI symptoms, are prone to developing AD. Therefore, identification of MCI patients is very critical for a plausible treatment before it reaches to AD, the irreversible stage of this neurodegenerative disease. Methods: Development of machine learning algorithms have recently gained a significant pace in early diagnosis of Alzheimer's disease (AD). In this study, a (2+1)D convolutional neural network (CNN) architecture has been proposed to distinguish mild cognitive impairment (MCI) from AD, based on structural magnetic resonance imaging (MRI). MRI scans of AD and MCI subjects were procured from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. 507 scans of 223 AD patients and 507 scans of 204 MCI patients were obtained for theHighlights: (2+1)D Convolutional Neural Network method was proposed to distinguish Mild Cognitive Impairment from Alzheimer Disease. Compared to 3D CNN methods (2+1)D provided better accuracy with an almost two times faster performance. Abstract: Background and objective: Dementia refers to the loss of memory and other cognitive abilities. Alzheimer's disease (AD), which patients eventually die from, is the most common cause of dementia. In USA, %60 to %80 of dementia cases, are caused by AD. An estimate of 5.2 million people from all age groups have been diagnosed with AD in 2014. Mild cognitive impairment (MCI) is a preliminary stage of dementia with noticeable changes in patient's cognitive abilities. Individuals, who bear MCI symptoms, are prone to developing AD. Therefore, identification of MCI patients is very critical for a plausible treatment before it reaches to AD, the irreversible stage of this neurodegenerative disease. Methods: Development of machine learning algorithms have recently gained a significant pace in early diagnosis of Alzheimer's disease (AD). In this study, a (2+1)D convolutional neural network (CNN) architecture has been proposed to distinguish mild cognitive impairment (MCI) from AD, based on structural magnetic resonance imaging (MRI). MRI scans of AD and MCI subjects were procured from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. 507 scans of 223 AD patients and 507 scans of 204 MCI patients were obtained for the computational experiments. Results: The outcome and robustness of 2D convolutions, 3D convolutions and (2+1)D convolutions were compared. The CNN algorithms incorporated 2 to 6 convolutional layers, depending on the architecture, followed by 4 pooling layers and 3 fully connected layers. (2+1)D convolutional neural network model resulted in the best classification performance with 85% auc score, in addition to an almost two times faster convergence compared to classical 3D CNN methods. Conclusions: Application of (2+1)D CNN algorithm to large datasets and deeper neural network models can provide a significant advantage in speed, due to its architecture handling images in spatial and temporal dimensions separately. … (more)
- Is Part Of:
- Computer methods and programs in biomedicine. Volume 221(2022)
- Journal:
- Computer methods and programs in biomedicine
- Issue:
- Volume 221(2022)
- Issue Display:
- Volume 221, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 221
- Issue:
- 2022
- Issue Sort Value:
- 2022-0221-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-06
- Subjects:
- CNN -- Spatio-temporal convolution -- Deep learning -- MRI -- Alzheimer's disease
Medicine -- Computer programs -- Periodicals
Biology -- Computer programs -- Periodicals
Computers -- Periodicals
Medicine -- Periodicals
Médecine -- Logiciels -- Périodiques
Biologie -- Logiciels -- Périodiques
Biology -- Computer programs
Medicine -- Computer programs
Periodicals
Electronic journals
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01692607 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.cmpb.2022.106825 ↗
- Languages:
- English
- ISSNs:
- 0169-2607
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3394.095000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22100.xml